Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings

Toxicology Letters

Volumn 191, Issue 2-3, 2009, Pages 305-313

  Rosas Hernández, Héctor ^a   Jiménez Badillo, Salma ^a   Martínez Cuevas, Pedro P ^a   Gracia Espino, Eduardo ^b   Terrones, Humberto ^b   Terrones, Mauricio ^b   Hussain, Saber M ^c   Ali, Syed F ^d   González, Carmen ^a,d  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^c AIR FORCE RESEARCH LABORATORY   (United States)

^d Neurochemistry Laboratory   (United States)

Author keywords

Aortic rings; Cytotoxicity; Endothelial cells; Nitric oxide; Silver nanoparticles

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NANOPARTICLE; NITRIC OXIDE; SERINE; SILVER;

ADULT ANIMAL; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

ANIMALS; AORTA; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE TONUS; NANOPARTICLES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SILVER; VASOCONSTRICTION;

RATTUS;

EID: 70449528321     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.09.014     Document Type: Article

References (44)

1. Arai S., Harada N., Kubo N., Shen J., Nakamura A., Ikeda H., Tsuji H., and Yamashita T. Induction of inducible nitric oxide synthase and apoptosis by LPS and TNF-α in nasal microvascular endothelial cells. Acta Oto-Laryngolog. 128 (2008) 78-85
2. Boop S.K., and Lettieri T. Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line. BMC Pharmacol. 8 (2008) 8-19
3. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S., Barnathan E.S., McCrae K.R., Hug B.A., Schmidt A.M., and Ster D.M. Endothelial cells in physiology and in the pathophysiology of cardiovascular disorders. Blood 91 (1998) 3527-3561
4. Clapp C., Aranda J., González C., Jeziorski M.C., and Martínez de la Escalera G. Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol. Metab. 17 (2006) 301-307
5. Courtois A., Andujar P., Ladeiro Y., Baudrimont I., Delannoy E., Leblais V., Begueret H., Galland M.A.B., Brochard P., Marano F., Marthan R., and Muller B. Impairment of NO-dependent relaxation in intralobar pulmonary arteries: comparison of urban particulate matter and manufactured nanoparticles. Environ. Health Perspect. 116 (2008) 1294-1299
6. Cui D., Tian F., Ozkan C.S., Wang M., and Gao H. Effects of single wall carbon nanotubes on human HEK293 cells. Toxicol. Lett. 155 (2005) 73-85
7. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival, modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986) 271-277
8. Furno F., Morley K.S., Wong B., Sharp B.L., Arnold P.L., Howdle S.M., Bayston R., Brown P.D., Windship P.D., and Reid H.J. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?. J. Antimicrob. Chemother. 54 (2004) 1019-1024
9. García C., Aranda J., Arnold E., Thebault S., Macotela Y., López-Casillas F., Mendoza V., Quiroz-Mercado H., Herández-Montiel H.L., Lin S.H., Martínez de la Escalera G., and Clapp C. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J. Clin. Invest. 118 (2008) 2291-2300
10. Gojova A., Guo B., Kota R.S., Rutledge J.C., Kennedy I.M., and Barakat A.I. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Perspect. 115 (2007) 403-409
11. Gonzalez C., Corbacho A.M., Eiserich J.P., Garcia C., Lopez-Barrera F., Morales-Tlalpan V., Barajas-Espinosa A., Diaz-Muñoz M., Rubio R., Lin S.H., Matinez de la Escalera G., and Clapp C. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 145 (2004) 5714-5722
12. Grant K., Loizidou M., and Taylor I. Endothelin-I: a multifunctional molecule in cancer. Cancer Res. UK 88 (2003) 163-166
13. Gwinn M.R., and Vallyathan V. Nanoparticles: health effects-pros and cons. Environ. Health Perspect. 114 (2006) 1818-1825
14. Hellerman Gr., Flam B.R., Eichler D.C., and Solomonson L.P. Stimulation of receptor-mediated nitric oxide production by vanadate. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2045-2050
15. Hsin Y.H., Chen C.F., Huang S., Shih T.S., Lai P.S., and Chueh P.J. The apoptotic effects of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 179 (2008) 130-139
16. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., and Schlager J.J. In vitro toxicity of nanoparticles in BLA 3A rat liver cells. Toxicol. In Vitro 19 (2005) 975-983
17. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., and Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. 92 (2006) 456-463
18. Kalishwaralal K., Banumathi E., Ram Kumar Pandian S., Deepak V., Muniyandi J., Hyun Eom S., and Gurnathan S. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf. B: Bio Interf. 73 (2009) 51-57
19. Kelm M., and Schrader J. Nitric oxide release form the isolated guinea pig heart. Eur. J. Pharm. 155 (1988) 317-321
20. Kim Y.S., Kim J.S., Cho H.S., Rha D.S., and Kim J.M. Twenty-eight-day oral toxicity, genotoxicity and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20 (2008) 575-583
21. Koshida R., Ou J., Matsunaga T., and Chilian W.M. Angiostatin: a negative regulator of endothelial-dependent vasodilation. Circulation 107 (2003) 803-806
22. Li Z., Carter J.D., Dailey L.A., and Huang Y.T. Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS. Environ. Health Perspect. 112 (2004) 201-206
23. Martini J.F., Piot C., Humeau L.M., Struman I., Martial J.A., and Weiner R.I. The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation. Mol. Endocrinol. 14 (2000) 1536-1549
24. Medina C., Santos-Martinez M.J., Radomski A., Corigan O.I., and Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 150 (2007) 552-558
25. Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Symes J.F., Fishman M.C., Huang P.L., and Isner J.M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101 (1998) 2567-2578
26. Nemmar A., Hoylaerts M.F., Hoet P.H., and Nemery B. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombic effects. Toxicol. Lett. 149 (2004) 243-253
27. Niu J., Azfer A., Rogers L.M., Wang X., and Kolattukudt P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res. 73 (2007) 549-559
28. Oberdöster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., and Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 6 (2005) 2-8
29. Parenti A., Morbidelli L., Ledda F., Harris J.G., and Ziche M. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway1. FASEB J. 15 (2001) 1487-1489
30. Papapetropoulos A., Fulton D., Lin M.I., Fontana J., McCabe T.J., and Zoellner S. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein. Mol. Pharmacol. 65 (2004) 407-415
31. Peters K., Unger R.E., Kirkpatrick C.J., Gatti A.M., and Monari E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci. Mater. Med. 15 (2004) 321-325
32. Prabhu, B.M., Ali, S.F., Hussain, S.M., Srivatsan, M., in press. Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rats. Nanotoxicology.
33. Rahman M.F., Wang J., Patterson T.A., Saini U.T., Robinson B.L., Newport G.D., Murdock R.C., Schlager J.J., Hussain S.M., and Ali S.F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 187 (2009) 15-21
34. Rodríguez-Manzo J.A., Terrones M., Terrones H., Kroto H.W., Sun L., and Banhart F. In situ nucleation of carbon nanotubes by the injection of carbon atoms into metal particles. Nat. Nanotechnol. 2 (2007) 307-311
35. Savage N., Thomas T.A., and Duncan J.S. Nanotechnology applications and implications research supported by the US Environmental Protection Agency STAR grants program. J. Environ. Monit. 9 (2007) 1046-1054
36. 2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H63-H71
37. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258 (1992) 1898-1902
38. Takenaka S., Karg E., Roth C., Schulz H., Ziesenis A., Heinzmann U., Schramel P., and Heyder J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 4 (2001) 547-551
39. Urbich C., Reissner A., Chavakis E., Dernbach E., Haendeler J., Fleming I., Zeiher A.M., Kaszkin M., and Dimmeler S. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J. 16 (2002) 706-708
40. Walford G., and Loscalzo J. Nitric oxide in vascular biology. J. Thromb. Haemost. 1 (2003) 2112-2118
41. Wu X., and Brunchez M.P. Labeling cellular targets with semiconductor quantum dot conjugates. Methods Cell Biol. 75 (2004) 171-183
42. Yamawaki H., and Iwai N. Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ. J. 70 (2006) 129-140
43. Yin J.-J., Lao F.-., Fu P.P., Wamer W.G., Zaho Y., Wang P.C., Qiu Y., Sun B., Xing G., Dong J., Liang X.-J., and Chen C. The scavenging of reactive oxygen species and the potential for cell protection by functionalized materials. Biomaterials 30 (2009) 611-621
44. Ziche M., and Morbidelli L. Nitric oxide in angiogenesis. J. Neurooncol. 50 (2000) 139-148